Fostair: new beclometasone/ formoterol CFC‐free combination
Authors
Abstract
Fostair is the first beclometasone/formoterol combination for the treatment of asthma. Here, Steve Chaplin describes the clinical trial data relating to its efficacy and safety, and Dr Ind comments on its place in therapy. Copyright © 2008 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.260 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
